The role of the proto-oncogene ETS2 in acute megakaryocytic leukemia biology and therapy. [electronic resource]
Producer: 20080327Description: 521-9 p. digitalISSN:- 1476-5551
- Acute Disease
- Cell Differentiation -- genetics
- Child
- Chromosomes, Human, Pair 21 -- genetics
- Cytarabine -- pharmacology
- Daunorubicin -- pharmacology
- Down Syndrome -- complications
- Drug Resistance, Neoplasm -- genetics
- Erythroid Precursor Cells -- metabolism
- Erythropoiesis -- genetics
- GATA1 Transcription Factor -- genetics
- Gene Dosage
- Gene Expression Regulation, Leukemic -- genetics
- Genetic Predisposition to Disease
- Humans
- K562 Cells -- drug effects
- Leukemia, Megakaryoblastic, Acute -- etiology
- Leukemia, Myeloid -- drug therapy
- Megakaryocytes -- drug effects
- Neoplasm Proteins -- biosynthesis
- Proto-Oncogene Mas
- Proto-Oncogene Protein c-ets-2 -- physiology
- Thrombopoiesis -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.